GLP-1RA essentials in gastroenterology: side effect management, precautions for endoscopy and applications for gastrointestinal disease treatment
Ozempic is approved by the Food and Drug Administration (FDA) for the following uses: to improve blood sugar management in adults who have type 2 diabetes, when used along with diet and exercise to reduce the risk of major cardiovascular events (those related to the heart and blood vessels, such as heart attack, stroke, and death) in adults who have type 2 diabetes and cardiovascular disease to reduce the risk of complications from chronic kidney disease in adults with type 2 diabetes The FDA has not approved Ozempic for weight loss or long-term weight management
The underlying mechanism for the increased HR has not yet been fully elucidated
AOD 9604 Studies on Obesity Models In obese murine models, both growth hormone and AOD 9604 have been linked to reductions in body fat mass, though the outcomes appeared different in lean models
What does the Precision Peptide Genetic Test measure
Mechanism, dosing, evidence, and what the research does not yet support